Holocene Advisors, LP Repligen Corp Transaction History

Holocene Advisors, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $6.4 Million - $7.81 Million	37,474 Added 12.29%	342,388 $63 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $34.8 Million - $56.5 Million	304,914 New	304,914 $54.8 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $50 Million - $83.3 Million	-256,780 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $12.6 Million - $16.8 Million	76,048 Added 42.08%	256,780 $51.3 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $8.97 Million - $11.3 Million	-49,745 Reduced 21.58%	180,732 $35.1 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $8.64 Million - $12.1 Million	-58,362 Reduced 20.21%	230,477 $44.2 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $35.4 Million - $45.7 Million	288,839 New	288,839 $42.6 Million
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $230,847 - $307,970	-6,547 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $202,433 - $244,006	6,547 New	6,547 $237,000

479

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.22B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.